PortfoliosLab logoPortfoliosLab logo
QVCGA vs. ENTA
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

QVCGA vs. ENTA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in QVC Group Inc (QVCGA) and Enanta Pharmaceuticals, Inc. (ENTA). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period


QVCGA

1D
0.00%
1M
YTD
6M
1Y
3Y*
5Y*
10Y*

ENTA

1D
-1.86%
1M
-27.84%
YTD
-29.80%
6M
-21.93%
1Y
48.19%
3Y*
-24.76%
5Y*
-25.36%
10Y*
-7.18%
*Multi-year figures are annualized to reflect compound growth (CAGR)

QVCGA vs. ENTA - Yearly Performance Comparison


2026 (YTD)
QVCGA
QVC Group Inc
0.00%
ENTA
Enanta Pharmaceuticals, Inc.
-16.33%

Fundamentals

Market Cap

QVCGA:

$2.75M

ENTA:

$319.83M

EPS

QVCGA:

-$302.09

ENTA:

-$2.67

PS Ratio

QVCGA:

0.00

ENTA:

3.72

Total Revenue (TTM)

QVCGA:

$9.23B

ENTA:

$69.21M

Gross Profit (TTM)

QVCGA:

$2.89B

ENTA:

$33.44M

EBITDA (TTM)

QVCGA:

$789.00M

ENTA:

-$61.85M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

QVCGA vs. ENTA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

QVCGA

ENTA
ENTA Risk / Return Rank: 6868
Overall Rank
ENTA Sharpe Ratio Rank: 5858
Sharpe Ratio Rank
ENTA Sortino Ratio Rank: 7474
Sortino Ratio Rank
ENTA Omega Ratio Rank: 7373
Omega Ratio Rank
ENTA Calmar Ratio Rank: 6969
Calmar Ratio Rank
ENTA Martin Ratio Rank: 6666
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

QVCGA vs. ENTA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for QVC Group Inc (QVCGA) and Enanta Pharmaceuticals, Inc. (ENTA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

QVCGA vs. ENTA - Sharpe Ratio Comparison


Loading charts...

Sharpe Ratios by Period


QVCGAENTADifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.44

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.35

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.12

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.05

Drawdowns

QVCGA vs. ENTA - Drawdown Comparison

The maximum QVCGA drawdown since its inception was 0.00%, smaller than the maximum ENTA drawdown of -96.63%. Use the drawdown chart below to compare losses from any high point for QVCGA and ENTA.


Loading charts...

Drawdown Indicators


QVCGAENTADifference

Max Drawdown

Largest peak-to-trough decline

0.00%

-96.63%

+96.63%

Max Drawdown (1Y)

Largest decline over 1 year

-34.30%

Max Drawdown (3Y)

Largest decline over 3 years

-83.61%

Max Drawdown (5Y)

Largest decline over 5 years

-95.62%

Max Drawdown (10Y)

Largest decline over 10 years

-96.63%

Current Drawdown

Current decline from peak

0.00%

-91.24%

+91.24%

Average Drawdown

Average peak-to-trough decline

0.00%

-49.23%

+49.23%

Ulcer Index

Depth and duration of drawdowns from previous peaks

17.76%

Volatility

QVCGA vs. ENTA - Volatility Comparison


Loading charts...

Volatility by Period


QVCGAENTADifference

Volatility (1M)

Calculated over the trailing 1-month period

13.36%

Volatility (6M)

Calculated over the trailing 6-month period

35.53%

Volatility (1Y)

Calculated over the trailing 1-year period

0.00%

109.93%

-109.93%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

0.00%

73.36%

-73.36%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

0.00%

60.70%

-60.70%

Dividends

QVCGA vs. ENTA - Dividend Comparison

Neither QVCGA nor ENTA has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

QVCGA vs. ENTA - Financials Comparison

This section allows you to compare key financial metrics between QVC Group Inc and Enanta Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.001.00B2.00B3.00B4.00B20222023202420252026
2.68B
17.16M
(QVCGA) Total Revenue
(ENTA) Total Revenue
Values in USD except per share items
Portfolio Optimizer

Find the right allocation for QVCGA and ENTA

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer